首页> 外文期刊>Human Molecular Genetics >Variation in aggregation propensities among ALS-associated variants of SOD1: correlation to human disease.
【24h】

Variation in aggregation propensities among ALS-associated variants of SOD1: correlation to human disease.

机译:与ALS相关的SOD1变体之间聚集倾向的变化:与人类疾病的相关性。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

To date, 146 different mutations in superoxide dismutase 1 (SOD1) have been identified in patients with familial amyotrophic lateral sclerosis (ALS). The mean age of disease onset in patients inheriting mutations in SOD1 is 45-47 years of age. However, although the length of disease duration is highly variable, there are examples of consistent disease durations associated with specific mutations (e. g. A4V, less than 2 years). In the present study, we have used a large set of data from SOD1-associated ALS pedigrees to identify correlations between disease features and biochemical/biophysical properties of more than 30 different variants of mutant SOD1. Using a reliable cell culture assay, we show that all ALS-associated mutations in SOD1 increase the inherent aggregation propensity of the protein. However, the relative propensity to do so varied considerably among mutants. We were not able to explain the variation in aggregation rates by differences in known protein properties such as enzyme activity, protein thermostability, mutation position or degree of change in protein charge. Similarly, we were not able to explain variability in the duration of disease in SOD1-associated ALS pedigrees by these properties. However, we find that the majority of pedigrees in which patients exhibit reproducibly short disease durations are associated with mutations that show a high inherent propensity to induce aggregation of SOD1.
机译:迄今为止,在家族性肌萎缩性侧索硬化症(ALS)患者中已鉴定出146种不同的超氧化物歧化酶突变(SOD1)。继承了SOD1突变的患者发病的平均年龄为45-47岁。然而,尽管疾病持续时间的长度是高度可变的,但是存在与特定突变相关的持续疾病持续时间的实例(例如,A4V,小于2年)。在本研究中,我们使用了来自与SOD1相关的ALS家谱的大量数据,来识别疾病特征与30多种突变SOD1变体的生化/生物物理特性之间的相关性。使用可靠的细胞培养测定法,我们显示SOD1中所有与ALS相关的突变均会增加蛋白质的固有聚集倾向。但是,这样做的相对倾向在突变体之间差异很大。我们无法通过已知蛋白质特性(例如酶活性,蛋白质热稳定性,突变位置或蛋白质电荷变化程度)的差异来解释聚集速率的变化。同样,我们无法通过这些特性来解释与SOD1相关的ALS家谱中疾病持续时间的变异性。但是,我们发现,其中患者表现出可重复的疾病持续时间的大多数谱系与突变相关,这些突变显示出诱导SOD1聚集的高固有倾向。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号